脑小血管病与炎症的密切关系
The Close Relationship between Cerebral Small Blood Vessel Disease and Inflammation
DOI: 10.12677/ACM.2024.142562, PDF,   
作者: 田丹丹:西安医学院第一附属医院,陕西 西安;高 飞*:西安医学院第一附属医院神经内科,陕西 西安
关键词: 脑小血管病炎症Cerebral Small Blood Vessel Disease Inflammation
摘要: 脑小血管病近年来发病率逐年增加,造成了社会巨大的经济负担,与年龄相关的CSVD亦在逐年上升,最常见的表现是脑卒中及认知障碍。临床前研究和临床研究均提示脑小血管病与炎症存在一定的相关关系,因此本文综述了炎症和CSVD病理生理进展的最新研究。
Abstract: In recent years, the incidence of cerebral small vascular disease has increased year by year, causing a huge economic burden on the society. The age-related CSVD is also increasing year by year. The most common manifestations are stroke, cognitive impairment, and even dementia. Both preclini-cal studies and clinical research suggest that there is a correlation between cerebral small vessel disease and inflammation. Based on this, this paper reviews the latest studies on the pathophysiol-ogy of inflammation and CSVD, and explores the potential link between inflammation and age-related CSVD, in order to provide new ideas for further research in diagnosis and treatment.
文章引用:田丹丹, 高飞. 脑小血管病与炎症的密切关系[J]. 临床医学进展, 2024, 14(2): 4052-4058. https://doi.org/10.12677/ACM.2024.142562

参考文献

[1] Wardlaw, J.M., Smith, C. and Dichgans, M. (2013) Mechanisms of Sporadic Cerebral Small Vessel Disease: Insights from Neuroimaging. The Lancet Neurology, 12, 483-497. [Google Scholar] [CrossRef
[2] Li, Q., et al. (2018) Cerebral Small Vessel Disease. Cell Transplantation, 27, 1711-1722. [Google Scholar] [CrossRef] [PubMed]
[3] Wardlaw, J.M., et al. (2013) Neuroimaging Standards for Re-search into Small Vessel Disease and Its Contribution to Ageing and Neurodegeneration. The Lancet Neurology, 12, 822-838. [Google Scholar] [CrossRef
[4] Cannistraro, R.J., et al. (2019) CNS Small Vessel Disease: A Clinical Review. Neurology, 92, 1146-1156. [Google Scholar] [CrossRef
[5] Pantoni, L. (2010) Cerebral Small Vessel Disease: from Pathogenesis and Clinical Characteristics to Therapeutic Challenges. The Lancet Neurology, 9, 689-701. [Google Scholar] [CrossRef
[6] Wang, Z., et al. (2021) Risk Factors of Cerebral Small Ves-sel Disease: A Systematic Review and Meta-Analysis. Medicine (Baltimore), 100, e28229. [Google Scholar] [CrossRef
[7] Kim, H., et al. (2013) Obstructive Sleep Apnea as a Risk Factor for Cerebral White Matter Change in a Middle-Aged and Older General Population. Sleep, 36, 709-715. [Google Scholar] [CrossRef] [PubMed]
[8] Backhouse, E.V., et al. (2017) Early Life Risk Factors for Cerebrovascular Disease: A Systematic Review and Meta-Analysis. Neurology, 88, 976-984. [Google Scholar] [CrossRef
[9] De Leeuw, F.E., et al. (2001) Prevalence of Cerebral White Matter Lesions in Elderly People: A Population Based Magnetic Resonance Imaging Study. The Rotterdam Scan Study. Journal of Neurology, Neurosurgery and Psychiatry, 70, 9-14. [Google Scholar] [CrossRef] [PubMed]
[10] Hilal, S., et al. (2017) Prevalence, Risk Factors and Consequences of Cerebral Small Vessel Diseases: Data from Three Asian Coun-tries. Journal of Neurology, Neurosurgery and Psychiatry, 88, 669-674. [Google Scholar] [CrossRef] [PubMed]
[11] Poels, M.M., et al. (2010) Prevalence and Risk Factors of Cerebral Microbleeds: An Update of the Rotterdam Scan Study. Stroke, 41, S103-S106. [Google Scholar] [CrossRef
[12] Obermeier, B., Daneman, R. and Ransohoff, R.M. (2013) Development, Maintenance and Disruption of the Blood-Brain Barrier. Nature Medicine, 19, 1584-1596. [Google Scholar] [CrossRef] [PubMed]
[13] Keaney, J. and Campbell, M. (2015) The Dynamic Blood-Brain Barrier. The FEBS Journal, 282, 4067-4079. [Google Scholar] [CrossRef] [PubMed]
[14] Kleinberger, G., et al. (2017) The FTD-Like Syndrome Causing TREM2 T66M Mutation Impairs Microglia Function, Brain Perfusion, and Glucose Metabolism. The EMBO Journal, 36, 1837-1853. [Google Scholar] [CrossRef] [PubMed]
[15] Liebner, S., et al. (2018) Functional Morphology of the Blood-Brain Barrier in Health and Disease. Acta Neuropathologica, 135, 311-336. [Google Scholar] [CrossRef] [PubMed]
[16] Dudvarski Stankovic, N., et al. (2016) Microglia-Blood Vessel Interactions: A Double-Edged Sword in Brain Pathologies. Acta Neuropathologica, 131, 347-363. [Google Scholar] [CrossRef] [PubMed]
[17] Varatharaj, A. and Galea, I. (2017) The Blood-Brain Barrier in Systemic Inflammation. Brain, Behavior, and Immunity, 60, 1-12. [Google Scholar] [CrossRef] [PubMed]
[18] Haruwaka, K., et al. (2019) Dual Microglia Effects on Blood Brain Barrier Permeability Induced by Systemic Inflammation. Nature Communications, 10, Article No. 5816. [Google Scholar] [CrossRef] [PubMed]
[19] Jalal, F.Y., et al. (2015) Hypoxia-Induced Neuroinflammatory White-Matter Injury Reduced by Minocycline in SHR/SP. Journal of Cerebral Blood Flow & Metabolism, 35, 1145-1153. [Google Scholar] [CrossRef] [PubMed]
[20] Ueno, M., et al. (2002) Blood-Brain Barrier Disruption in White Matter Lesions in a Rat Model of Chronic Cerebral Hypoperfusion. Journal of Cerebral Blood Flow & Metabo-lism, 22, 97-104. [Google Scholar] [CrossRef] [PubMed]
[21] Tomimoto, H., et al. (1996) Alterations of the Blood-Brain Barrier and Glial Cells in White-Matter Lesions in Cerebrovascular and Alzheimer’s Disease Patients. Stroke, 27, 2069-2074. [Google Scholar] [CrossRef
[22] Forsberg, K.M.E., et al. (2018) Endothelial Dam-age, Vascular Bagging and Remodeling of the Microvascular Bed in Human Microangiopathy with Deep White Matter Lesions. Acta Neuropathologica Communications, 6, Article No. 128. [Google Scholar] [CrossRef] [PubMed]
[23] Young, V.G., Halliday, G.M. and Kril, J.J. (2008) Neuropatho-logic Correlates of White Matter Hyperintensities. Neurology, 71, 804-811. [Google Scholar] [CrossRef] [PubMed]
[24] Wardlaw, J.M., et al. (2009) Lacunar Stroke Is Associ-ated with Diffuse Blood-Brain Barrier Dysfunction. Annals of Neurology, 65, 194-202. [Google Scholar] [CrossRef] [PubMed]
[25] Topakian, R., et al. (2010) Blood-Brain Barrier Permeability Is Increased in Normal-Appearing White Matter in Patients with Lacunar Stroke and Leucoaraiosis. Journal of Neurology, Neurosurgery and Psychiatry, 81, 192-197. [Google Scholar] [CrossRef] [PubMed]
[26] Held, C., et al. (2017) Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. Journal of the American Heart Association, 6, e005077. [Google Scholar] [CrossRef
[27] Nakahira, K., et al. (2011) Autophagy Proteins Regulate Innate Immune Responses by Inhibiting the Release of Mitochondrial DNA Mediated by the NALP3 Inflammasome. Nature Immunology, 12, 222-230. [Google Scholar] [CrossRef] [PubMed]
[28] Oka, T., et al. (2012) Mitochondrial DNA That Escapes from Autophagy Causes Inflammation and Heart Failure. Nature, 485, 251-255. [Google Scholar] [CrossRef] [PubMed]
[29] Martinvalet, D. (2018) The Role of the Mitochondria and the Endoplasmic Reticulum Contact Sites in the Development of the Immune Responses. Cell Death & Disease, 9, Article No. 336. [Google Scholar] [CrossRef] [PubMed]
[30] Farkas, E., et al. (2004) Experimental Cerebral Hypoperfusion Induces White Matter Injury and Microglial Activation in the Rat Brain. Acta Neuropathologica, 108, 57-64. [Google Scholar] [CrossRef] [PubMed]
[31] Jalal, F.Y., et al. (2012) Myelin Loss Associated with Neuroin-flammation in Hypertensive Rats. Stroke, 43, 1115-1122. [Google Scholar] [CrossRef
[32] Kaiser, D., et al. (2014) Spontaneous White Matter Dam-age, Cognitive Decline and Neuroinflammation in Middle-Aged Hypertensive Rats: An Animal Model of Early-Stage Cerebral Small Vessel Disease. Acta Neuropathologica Communications, 2, Article No. 169. [Google Scholar] [CrossRef] [PubMed]
[33] Wan, S., et al. (2023) Plasma Inflammatory Biomarkers in Cere-bral Small Vessel Disease: A Review. CNS Neuroscience & Therapeutics, 29, 498-515. [Google Scholar] [CrossRef] [PubMed]
[34] Ling, C., et al. (2021) The Effect of Race and Shear Stress on CRP-Induced Responses in Endothelial Cells. Mediators of Inflammation, 2021, Article ID: 6687250. [Google Scholar] [CrossRef] [PubMed]
[35] Pasceri, V., Willerson, J.T. and Yeh, E.T. (2000) Direct Proinflamma-tory Effect of C-Reactive Protein on Human Endothelial Cells. Circulation, 102, 2165-2168. [Google Scholar] [CrossRef
[36] Nishida, E., et al. (2016) Serum Amyloid A Promotes E-Selectin Expression via Toll-Like Receptor 2 in Human Aortic Endothelial Cells. Mediators of Inflammation, 2016, Article ID: 7150509. [Google Scholar] [CrossRef] [PubMed]
[37] Eber, B. and Schumacher, M. (1993) Fibrinogen: Its Role in the Hemostatic Regulation in Atherosclerosis. Seminars in Thrombosis and Hemostasis, 19, 104-107. [Google Scholar] [CrossRef] [PubMed]
[38] Lominadze, D., et al. (2010) Mechanisms of Fibrinogen-Induced Mi-crovascular Dysfunction during Cardiovascular Disease. Acta Physiologica (Oxf), 198, 1-13. [Google Scholar] [CrossRef] [PubMed]
[39] Lominadze, D., et al. (2005) Fibrinogen and Fragment D-Induced Vascular Constriction. American Journal of Physiology-Heart and Circulatory Physiology, 288, H1257-H1264. [Google Scholar] [CrossRef] [PubMed]
[40] Muradashvili, N., et al. (2011) Fibrinogen Alters Mouse Brain Endothelial Cell Layer Integrity Affecting Vascular Endothelial Cadherin. Biochemical and Biophysical Re-search Communications, 413, 509-514. [Google Scholar] [CrossRef] [PubMed]
[41] Patibandla, P.K., et al. (2009) Fibrinogen Induces Alterations of Endothelial Cell Tight Junction Proteins. Journal of Cellular Physiology, 221, 195-203. [Google Scholar] [CrossRef] [PubMed]
[42] Tarkowski, E., et al. (2003) Correlation between Intrathecal Sulfatide and TNF-Alpha Levels in Patients with Vascular Dementia. Dementia and Geriatric Cognitive Disorders, 15, 207-211. [Google Scholar] [CrossRef] [PubMed]
[43] Guldiken, B., et al. (2007) Serum Osteoprotegerin Levels in Patients with Acute Atherothrombotic Stroke and Lacunar Infarct. Thrombosis Research, 120, 511-516. [Google Scholar] [CrossRef] [PubMed]
[44] Schoch, H.J., Fischer, S. and Marti, H.H. (2002) Hypox-ia-Induced Vascular Endothelial Growth Factor Expression Causes Vascular Leakage in the Brain. Brain, 125, 2549-2557. [Google Scholar] [CrossRef] [PubMed]
[45] Zhang, J.B., et al. (2016) Association of Serum Vascular Endothelial Growth Factor Levels and Cerebral Microbleeds in Patients with Alzheimer’s Disease. European Journal of Neurology, 23, 1337-1342. [Google Scholar] [CrossRef] [PubMed]
[46] Perkins, L.A., Anderson, C.J. and Novelli, E.M. (2019) Targeting P-Selectin Adhesion Molecule in Molecular Imaging: P-Selectin Expression as a Valuable Imaging Biomarker of In-flammation in Cardiovascular Disease. Journal of Nuclear Medicine, 60, 1691-1697. [Google Scholar] [CrossRef] [PubMed]
[47] De Leeuw, F.E., et al. (2002) Endothelial Cell Activation Is Asso-ciated with Cerebral White Matter Lesions in Patients with Cerebrovascular Disease. Annals of the New York Academy of Sciences, 977, 306-314. [Google Scholar] [CrossRef] [PubMed]
[48] Fassbender, K., et al. (1999) Adhesion Molecules in Cerebrovascular Diseases. Evidence for an Inflammatory Endothelial Activation in Cerebral Large- and Small-Vessel Disease. Stroke, 30, 1647-1650. [Google Scholar] [CrossRef
[49] Kario, K., et al. (2001) Hyperinsulinemia and Hemostatic Abnor-malities Are Associated with Silent Lacunar Cerebral Infarcts in Elderly Hypertensive Subjects. Journal of the American College of Cardiology, 37, 871-877. [Google Scholar] [CrossRef
[50] Low, A., et al. (2019) Inflammation and Cerebral Small Vessel Disease: A Systematic Review. Ageing Research Reviews, 53, Article 100916. [Google Scholar] [CrossRef] [PubMed]
[51] Wada, M., et al. (2011) Plasma Fibrinogen, Global Cognitive Func-tion, and Cerebral Small Vessel Disease: Results of a Cross-Sectional Study in Community-Dwelling Japanese Elderly. Internal Medicine, 50, 999-1007. [Google Scholar] [CrossRef] [PubMed]
[52] Fornage, M., et al. (2008) Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study. Stroke, 39, 1952-1959. [Google Scholar] [CrossRef
[53] Mitaki, S., et al. (2016) C-Reactive Protein Levels Are Associated with Cerebral Small Vessel-Related Lesions. Acta Neurologica Scandinavica, 133, 68-74. [Google Scholar] [CrossRef] [PubMed]
[54] Hilal, S., et al. (2018) C-Reactive Protein, Plasma Amyloid-β Levels, and Their Interaction with Magnetic Resonance Imaging Markers. Stroke, 49, 2692-2698. [Google Scholar] [CrossRef
[55] Koh, S.H., et al. (2011) Microbleeds and Free Active MMP-9 Are Independent Risk Factors for Neurological Deterioration in Acute Lacunar Stroke. European Journal of Neurology, 18, 158-164. [Google Scholar] [CrossRef] [PubMed]
[56] Noz, M.P., et al. (2018) Trained Immunity Characteristics Are Associated with Progressive Cerebral Small Vessel Disease. Stroke, 49, 2910-2917. [Google Scholar] [CrossRef
[57] Vermeer, S.E., et al. (2002) Homocysteine, Silent Brain Infarcts, and White Matter Lesions: The Rotterdam Scan Study. Annals of Neurology, 51, 285-289. [Google Scholar] [CrossRef] [PubMed]
[58] Pavlovic, A.M., et al. (2011) Increased Total Homocysteine Level Is Asso-ciated with Clinical Status and Severity of White Matter Changes in Symptomatic Patients with Subcortical Small Vessel Disease. Clinical Neurology and Neurosurgery, 113, 711-715. [Google Scholar] [CrossRef] [PubMed]
[59] Gao, Y., et al. (2015) Homocysteine Level Is Associated with White Matter Hyperintensity Locations in Patients with Acute Ischemic Stroke. PLOS ONE, 10, e0144431. [Google Scholar] [CrossRef] [PubMed]
[60] Altendahl, M., et al. (2020) An IL-18-Centered Inflammatory Network as a Biomarker for Cerebral White Matter Injury. PLOS ONE, 15, e0227835. [Google Scholar] [CrossRef] [PubMed]